Key result
Prehypertension in young adult males was associated with a higher prevalence of abnormally high left ventricular mass index compared to normotension.
Why the study?
Does prehypertension increase the risk of abnormal left ventricular mass index in young adult males compared to normotension?
Cross-Sectional (n=200)
No
Does prehypertension increase the risk of abnormal left ventricular mass index in young adult males compared to normotension?
Prehypertension is associated with a significantly higher prevalence of abnormally high left ventricular mass index in young adult males, suggesting early structural cardiac changes.
Answers are grounded in this paper and cite their sources.
May indicate early LV remodeling risk; leaves open whether screening or intervention improves outcomes in young males.
BACKGROUND who have prehypertension are at increased risk of developing hypertension and CVDs, compared to normotensives. has been reported to be associated with LV structural and geometric abnormality. It has also been found that LV mass itself may be a predictor of future hypertension. Hence, as PHT and LV mass portend a risk of future , their simultaneous existence may have an additive role, nevertheless this needs to be determined. Despite this, no pharmacotherapy is recommended for pre-hypertensions. This study was aimed to assess effect of prehypertension LV mass index in young males and to evaluate the clinical associates of abnormal LV mass index. AND METHODS study was carried among young adult males admitted at a tertiary care teaching hospital. All study subjects underwent examination including anthropometric measurements and echocardiographic examination for determination of LV mass. found that 29 (14.5%) had abnormally high LVMI. Among prehypertensives 23% and among normotensives 6% had high LVMI. Older age and prehypertension were found to have higher odds of abnormal LVMI after multiple variable regression. has been proposed that pre-hypertension and high LVMI are associated with significant risk of future adverse events including emergence of hypertension. Our study further confirms this and supports the notion of screening for prehypertension and LVMI. Still, no pharmacotherapy is recommended for prehypertension which requires future studies to shed light upon this area.
No takes yet. Share an insight, caveat, or question.
Wanjari et al. (2018) conducted a cross-sectional in Prehypertension (n=200). Prehypertension vs. Normotension was evaluated on Abnormally high left ventricular mass index (LVMI). Prehypertension in young adult males was associated with a higher prevalence of abnormally high left ventricular mass index compared to normotension.
Synapse has enriched 10 related papers. Consider them for comparative context: